Henry Schein, Inc.
HSIC Healthcare Medical Distribution
Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024. In the quarter to June 2026, revenue grew 6.73%, EPS grew 16.9%, free cash flow grew 140.9% and total debt rose 15.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.
Follow HSIC
Henry Schein, Inc. (HSIC) Shares outstanding
Henry Schein, Inc.'s shares outstanding at the end of fiscal 2025 was $121.7M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $114.4M. Over the past ten years it has ranged from $121.7M (fiscal 2025) to $168.3M (fiscal 2015) — the current reading is the lowest in ten years. Henry Schein, Inc. ranks 4th of 10 Medical Distribution companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $121.7M | (4.74%) |
| FY2024 | $127.8M | (3.01%) |
| FY2023 | $131.7M | (4.36%) |
| FY2022 | $137.8M | (2.83%) |
| FY2021 | $141.8M | (1.14%) |
| FY2020 | $143.4M | (3.92%) |
| FY2019 | $149.3M | (2.90%) |
| FY2018 | $153.7M | (2.84%) |
| FY2017 | $158.2M | (3.37%) |
| FY2016 | $163.7M | (2.69%) |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $114.4M | (1.44%) |
| Mar 2026 | $116.1M | (4.65%) |
| Dec 2025 | $121.7M | 0.56% |
| Sep 2025 | $121.0M | (1.31%) |
| 42 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| CAH Cardinal Health, Inc. compare | $237.0M |
| COR Cencora, Inc. compare | $193.9M |
| MCK McKesson Corporation compare | $119.2M |
| HSIC Henry Schein, Inc. | $114.4M |
| ACH Accendra Health, Inc. compare | $76.7M |
| COSM Cosmos Health Inc. compare | $59.9M |
| FOCL FocalTherics compare | $35.5M |
| AHG Akso Health Group Sponsored ADR compare | $16.3M |
| HKPD Cellyan Biotechnology Co., Ltd compare | — |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on HSIC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement